CORRESP 1 filename1.htm

AIMEI HEALTH TECHNOLOGY CO., LTD
10 East 53rd Street, Suite 3001
New York, NY 10022

November 28, 2023

VIA EDGAR
U.S. Securities & Exchange Commission
100 F Street, NE
Washington, D.C. 20549

RE:

Aimei Health Technology Co., Ltd(the “Company”)
Registration Statement on Form S-1
(File No. 333-272230) (the “Registration Statement”)

Ladies and Gentlemen:

The Company hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the Registration Statement so that such Registration Statement will become effective as of 4:00 pm., Eastern Time, on November 30, 2023, or as soon thereafter as practicable.

The Company hereby acknowledges that:

	●	Should the Securities and Exchange Commission (the “Commission”) or the Staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;

	●	The action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and

	●	The Company may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

[Signature page follows]

	Very truly yours,

	Aimei Health Technology Co., Ltd

	By:	/s/ Juan Fernandez Pascual
	Name:	Juan Fernandez Pascual
	Title:	Chief Executive Officer